To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZHX1andC8orf76TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
630 supporting clones for gene ZHX1andC8orf76 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA317032 hippocampus .a 1 to 552 2 to 553   tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
CN352595 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 48 to 752 1 to 705       705/705
(100 %)
1 diff
(99.9 %id)
DA221949 brain .a 86 to 555 2 to 471   capped   470/470
(100 %)
0 diff
(100 %id)
DN992560 brain, whole brain .a 138 to 752 33 to 647       615/647
(95 %)
6 diff
(99.1 %id)
NM_001017926.1   .a 177 to 5190 1 to 5014 exact RefSeq, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 5014/5014
(100 %)
0 diff
(100 %id)
DA411207 thalamus .a 180 to 838 2 to 662   capped   661/662
(99 %)
4 diff
(99.4 %id)
DA492341 brain .a 180 to 758 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA781014 brain .a 196 to 766 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
DA112784 cerebellum .a 199 to 800 2 to 603   capped   602/602
(100 %)
0 diff
(100 %id)
DB221580 trachea .a 199 to 733 2 to 538   capped   537/537
(100 %)
3 diff
(99.5 %id)
DA106343 cerebellum .a 200 to 756 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA231118 brain .a 202 to 749 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA327941 hippocampus .a 206 to 738 2 to 531   capped   530/530
(100 %)
4 diff
(99.3 %id)
DA386430 thalamus .a 208 to 785 2 to 579   capped   578/578
(100 %)
0 diff
(100 %id)
DA446623 tongue, tumor tissue .a 208 to 787 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BM461738 leiomyosarcoma, uterus .a 209 to 1112 1 to 906       906/908
(99 %)
10 diff
(98.9 %id)
DB472490 hippocampus .a 210 to 697 1 to 488       488/488
(100 %)
2 diff
(99.6 %id)
DB482507 hippocampus .a 210 to 714 1 to 505       505/505
(100 %)
2 diff
(99.7 %id)
DA797516 brain .a 211 to 786 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA105850 cerebellum .a 212 to 759 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA102118 cerebellum .a 217 to 785 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA213545 brain .a 217 to 760 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA239990 brain .a 217 to 815 2 to 600   capped   599/600
(99 %)
1 diff
(99.9 %id)
DA414438 thalamus .a 217 to 777 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA970708 synovial membrane tissue from rheumatioidarthritis .a 217 to 668 2 to 453   capped   452/458
(98 %)
1 diff
(99.8 %id)
DB265064 uterus .a 217 to 801 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
DA121964 cerebellum .a 218 to 750 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA224479 brain .a 218 to 685 2 to 469   capped   468/468
(100 %)
3 diff
(99.4 %id)
DA230817 brain .a 218 to 789 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DB288350 uterus .a 218 to 753 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
DA115903 cerebellum .a 219 to 773 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA188303 amygdala .a 219 to 751 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA197364 brain .a 219 to 771 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA236090 brain .a 220 to 814 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA269499 caudate nucleus .a 220 to 784 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA400730 thalamus .a 220 to 756 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA402965 thalamus .a 220 to 806 2 to 588   capped   587/588
(99 %)
1 diff
(99.9 %id)
DA453842 tongue, tumor tissue .a 220 to 781 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DB092760 testis .a 220 to 779 2 to 562   capped   561/561
(100 %)
3 diff
(99.5 %id)
DB228372 trachea .a 220 to 779 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DB229853 trachea .a 220 to 812 2 to 594   capped   593/593
(100 %)
1 diff
(99.9 %id)
DA766164 tongue .a 222 to 795 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA335820 hippocampus .a 224 to 827 2 to 604   capped   603/603
(100 %)
1 diff
(99.9 %id)
DA408526 thalamus .a 224 to 772 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
BM749405 stomach .a 228 to 704 1 to 475       475/475
(100 %)
5 diff
(99.0 %id)
BX490328   .a 301 to 952 1 to 652       652/652
(100 %)
4 diff
(99.4 %id)
AA680145 liver and spleen .a 432 to 885 454 to 1       454/454
(100 %)
0 diff
(100 %id)
DA805280 brain .a 444 to 1020 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BP349091 brain .a 448 to 1028 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CN352596 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 477 to 1008 17 to 548       532/548
(97 %)
6 diff
(99.0 %id)
T86901 liver and spleen .a 483 to 877 412 to 10       403/415
(97 %)
0 diff
(100 %id)
W60373 heart .a 484 to 837 1 to 359       359/364
(98 %)
6 diff
(98.4 %id)
DA794422 brain .a 512 to 1028 2 to 519   capped   518/518
(100 %)
4 diff
(99.3 %id)
DB074367 testis .a 549 to 1088 2 to 541   tiling clone, capped   540/540
(100 %)
0 diff
(100 %id)
DA020831   .a 623 to 1189 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BP283782 bone marrow .a 639 to 1227 1 to 589       589/589
(100 %)
1 diff
(99.9 %id)
BG195158   .a 648 to 812 168 to 4     Submitted on the opposite strand 165/177
(93 %)
0 diff
(100 %id)
BP314469 mammary gland .a 651 to 1231 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP315618 mammary gland .a 653 to 1234 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA439599 tongue, tumor tissue .a 660 to 1222 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BP285192 lung .a 660 to 1239 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
DA786611 brain .a 666 to 1253 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA408791 thalamus .a 667 to 1312 2 to 647   capped   646/646
(100 %)
0 diff
(100 %id)
BP278757   .a 667 to 1249 1 to 584       584/588
(99 %)
4 diff
(99.4 %id)
BP358940 mammary gland .a 668 to 1248 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP194170 brain .a 672 to 1255 1 to 585       585/585
(100 %)
3 diff
(99.5 %id)
BP229564 brain .a 672 to 1250 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
DA658939   .a 673 to 1234 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BP352513   .a 673 to 1263 1 to 593       593/593
(100 %)
2 diff
(99.7 %id)
AF106862 Liver .a 678 to 4899 1 to 4220 exact tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 4220/4220
(100 %)
2 diff
(100.0 %id)
EL733809 mixed .a 702 to 1382 1 to 678       678/681
(99 %)
6 diff
(99.2 %id)
DA777753 brain .a 741 to 1323 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
BQ219159 leiomyosarcoma, uterus .a 828 to 1672 1 to 848       848/1021
(83 %)
5 diff
(99.6 %id)
DA789022 brain .a 842 to 1424 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA451304 tongue, tumor tissue .a 868 to 1432 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA414096 thalamus .a 932 to 1488 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
CN352594 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 979 to 1632 1 to 654       654/654
(100 %)
2 diff
(99.7 %id)
DA784118 brain .a 980 to 1556 2 to 578   capped   577/578
(99 %)
1 diff
(99.9 %id)
DA502392 brain .a 1027 to 1599 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA776524 brain .a 1033 to 1614 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DA090192 cerebellum .a 1041 to 1619 2 to 582   capped   581/581
(100 %)
4 diff
(99.4 %id)
BE779920 eye, retinoblastoma .a 1067 to 1803 1 to 734       734/941
(78 %)
17 diff
(98.2 %id)
DA477128   .a 1073 to 1636 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB268780 uterus .a 1094 to 1672 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DB015681 esophageal, tumor tissue .a 1096 to 1532 2 to 438   capped   437/496
(88 %)
2 diff
(99.6 %id)
DA145660 amygdala .a 1121 to 1682 2 to 564   capped   563/563
(100 %)
4 diff
(99.3 %id)
DB138174 thymus .a 1132 to 1693 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA968308 stomach .a 1144 to 1719 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA506377 brain .a 1160 to 1726 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA335883 hippocampus .a 1276 to 1881 2 to 608   capped   607/607
(100 %)
2 diff
(99.7 %id)
BP283441 bone marrow .a 1285 to 1866 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP283490 bone marrow .a 1285 to 1872 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
BE083081 breast .a 1300 to 1515 220 to 1     Submitted on the opposite strand 220/250
(88 %)
12 diff
(95.2 %id)
DA553805   .a 1412 to 1959 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BF337812 brain, glioblastoma with EGFR amplification .a 1486 to 2139 1 to 650       650/885
(73 %)
17 diff
(98.1 %id)
DA772391 brain .a 1661 to 2232 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
CN352593 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1693 to 2225 1 to 533       533/533
(100 %)
0 diff
(100 %id)
DA520321 brain .a 1713 to 2281 2 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
AL711412 human skeletal muscle .a 1740 to 2234 1 to 496       496/496
(100 %)
1 diff
(99.8 %id)
BM955961 tonsil .a 1792 to 2042 1 to 252       252/252
(100 %)
1 diff
(99.7 %id)
BP269824 thyroid .a 1856 to 2439 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BM832726 stomach .a 1897 to 2559 1 to 663       663/663
(100 %)
0 diff
(100 %id)
BM465348 eye, retinoblastoma .a 1914 to 2557 1 to 656       656/1005
(65 %)
18 diff
(98.3 %id)
BE883114 leiomyosarcoma, uterus .a 2012 to 2701 1 to 686       686/936
(73 %)
25 diff
(97.4 %id)
AI000795 Kidney .a 2026 to 2526 1 to 500     Submitted on the opposite strand 500/500
(100 %)
10 diff
(98.0 %id)
BM718784 eye, fetal eye .a 2077 to 2814 1 to 738       738/738
(100 %)
1 diff
(99.9 %id)
BX333844 Neuroblastoma Cot 50-normalized .a 2095 to 2872 1 to 780       780/780
(100 %)
8 diff
(99.0 %id)
CB125523 cervix, Uterine .a 2101 to 2619 1 to 518       518/518
(100 %)
2 diff
(99.7 %id)
BX280964 embryonal carcinoma, cell line, testis .a 2129 to 2602 1 to 474       474/474
(100 %)
2 diff
(99.6 %id)
BQ230291 embryonal carcinoma, cell line, testis .a 2131 to 3016 1 to 889       889/892
(99 %)
8 diff
(99.2 %id)
BP361476 thalamus .a 2160 to 2753 1 to 594       594/594
(100 %)
0 diff
(100 %id)
EC583081 Prostate .a 2163 to 2253 1 to 91       91/102
(89 %)
2 diff
(98.1 %id)
BE813803 breast_normal .a 2243 to 2686 450 to 8       443/450
(98 %)
0 diff
(100 %id)
T66785 whole brain .a 2251 to 2585 1 to 338       338/511
(66 %)
11 diff
(97.9 %id)
FN119705 breast carcinoma .a 2258 to 2359 101 to 1     Submitted on the opposite strand 101/101
(100 %)
1 diff
(99.1 %id)
DA099611 cerebellum .a 2313 to 2865 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BX486038   .a 2335 to 2651 1 to 318       318/318
(100 %)
1 diff
(99.7 %id)
AA167188   .a 2358 to 2732 1 to 374       374/374
(100 %)
3 diff
(99.2 %id)
AL833897 amygdala .a 2414 to 3222 1 to 809   available from DKFZ, AAA   809/2625
(30 %)
4 diff
(99.9 %id)
BX500722 Liver .a 2500 to 3020 8 to 529       522/529
(98 %)
6 diff
(98.9 %id)
DT218768 brain .a 2542 to 3135 1 to 594       594/594
(100 %)
2 diff
(99.7 %id)
DB105093 thymus .a 2549 to 3106 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BF341726 brain, glioblastoma with EGFR amplification .a 2564 to 3213 38 to 692       655/1203
(54 %)
15 diff
(98.8 %id)
BP221050 colon .a 2601 to 3150 1 to 550       550/550
(100 %)
5 diff
(99.1 %id)
AK025236 colon .a 2603 to 5196 1 to 2595   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2595/2595
(100 %)
8 diff
(99.7 %id)
D81698 brain .a 2603 to 3027 1 to 420       420/420
(100 %)
11 diff
(97.4 %id)
D81699 brain .a 2603 to 3027 1 to 420       420/420
(100 %)
11 diff
(97.4 %id)
CD672621 eye, Iris .a 2714 to 3346 1 to 633       633/633
(100 %)
1 diff
(99.9 %id)
AW884503 ovary .a 2723 to 3062 344 to 8       337/351
(96 %)
0 diff
(100 %id)
CN352592 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2734 to 3426 1 to 693       693/693
(100 %)
5 diff
(99.3 %id)
BF366116 nervous_tumor .a 2736 to 2974 1 to 240       240/240
(100 %)
13 diff
(94.6 %id)
AW891313 nervous_tumor .a 2748 to 2977 18 to 243       226/257
(87 %)
9 diff
(96.5 %id)
CR995893 T-Lymphocytes .a 2748 to 3500 1 to 749       749/750
(99 %)
11 diff
(98.6 %id)
BF366115 nervous_tumor .a 2753 to 2974 2 to 223       222/223
(99 %)
5 diff
(97.8 %id)
AW891332 nervous_tumor .a 2762 to 2988 1 to 225       225/232
(96 %)
8 diff
(96.6 %id)
AW891312 nervous_tumor .a 2767 to 2946 1 to 180       180/180
(100 %)
3 diff
(98.4 %id)
BX369041 Neuroblastoma Cot 50-normalized .a 2771 to 3508 1 to 738       738/911
(81 %)
6 diff
(99.4 %id)
DA367611 subthalamic nucleus .a 2824 to 3387 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BG105428 adrenal cortex carcinoma, cell line, adrenal gland .a 2845 to 3514 13 to 690       678/1143
(59 %)
29 diff
(97.5 %id)
BM827644 stomach .a 2851 to 3381 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
BP385480 pancreatic islet .a 2913 to 3504 592 to 1       592/592
(100 %)
0 diff
(100 %id)
FN109680 breast carcinoma .a 2915 to 2992 1 to 76       76/77
(98 %)
3 diff
(96.2 %id)
FN048004 breast carcinoma .a 2970 to 3080 1 to 110       110/111
(99 %)
2 diff
(98.2 %id)
FN173072 breast carcinoma .a 2970 to 3088 117 to 1     Submitted on the opposite strand 117/117
(100 %)
3 diff
(97.5 %id)
CD678242 eye, Trabecular meshwork .a 2972 to 3381 1 to 410       410/410
(100 %)
3 diff
(99.3 %id)
AL598656   .a 2983 to 3477 13 to 507       495/507
(97 %)
7 diff
(98.7 %id)
BF693279 muscle (skeletal) .a 2984 to 3709 1 to 750       750/911
(82 %)
51 diff
(94.5 %id)
FN141351 breast carcinoma .a 3001 to 3081 79 to 1     Submitted on the opposite strand 79/80
(98 %)
2 diff
(97.5 %id)
BG675208 skin .a 3005 to 3762 1 to 762       762/846
(90 %)
9 diff
(99.0 %id)
CD688289 normal nasopharynx .a 3008 to 3536 15 to 543       529/543
(97 %)
8 diff
(98.6 %id)
DA041079 bladder .a 3033 to 3593 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
AI984924 Kidney .a 3081 to 3766 689 to 1       689/689
(100 %)
40 diff
(94.2 %id)
AI123518 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 3084 to 3790 707 to 1       707/707
(100 %)
3 diff
(99.6 %id)
N75170 multiple sclerosis lesions .a 3088 to 3371 1 to 286       286/286
(100 %)
7 diff
(97.6 %id)
BP194844 brain .a 3090 to 3673 1 to 584       584/584
(100 %)
0 diff
(100 %id)
AA131614 uterus .a 3093 to 3326 1 to 237       237/254
(93 %)
5 diff
(98.1 %id)
DA572442 whole embryo, mainly body .a 3096 to 3795 2 to 702   capped   701/701
(100 %)
3 diff
(99.6 %id)
H25330 breast .a 3100 to 3414 1 to 317   fully sequenced,   317/317
(100 %)
3 diff
(99.1 %id)
BU742425 eye, fetal eye .a 3102 to 3805 704 to 1       704/704
(100 %)
1 diff
(99.9 %id)
BF155913 head_neck .a 3109 to 3336 230 to 2       229/230
(99 %)
0 diff
(100 %id)
BF111907 pooled .a 3114 to 3795 682 to 1       682/682
(100 %)
0 diff
(100 %id)
BQ007142 Chondrosarcoma, Left Pelvis .a 3116 to 3805 689 to 1       689/689
(100 %)
2 diff
(99.8 %id)
BQ001559 lung, Metastatic Chondrosarcoma .a 3116 to 3805 689 to 1       689/689
(100 %)
1 diff
(99.9 %id)
DB526314 testis .a 3128 to 3560 1 to 433     Submitted on the opposite strand 433/433
(100 %)
1 diff
(99.8 %id)
AI913358 Kidney .a 3135 to 3787 652 to 1       652/652
(100 %)
5 diff
(99.3 %id)
BQ003548 Chondrosarcoma, Left Pelvis .a 3141 to 3805 665 to 1       665/665
(100 %)
1 diff
(99.9 %id)
DA449050 tongue, tumor tissue .a 3149 to 3553 2 to 406   capped   405/405
(100 %)
0 diff
(100 %id)
TI_157612238   .a 3177 to 3787 707 to 96   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 612/613
(99 %)
12 diff
(98.1 %id)
AI742277 pooled .a 3180 to 3792 612 to 1       612/615
(99 %)
7 diff
(98.9 %id)
BM746105 stomach .a 3181 to 3565 1 to 386       386/386
(100 %)
4 diff
(99.0 %id)
W25576 heart .a 3191 to 3416 1 to 227       227/232
(97 %)
2 diff
(99.2 %id)
BP323080 Pancreas .a 3203 to 3783 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
R58771   .a 3240 to 3526 1 to 286       286/286
(100 %)
12 diff
(95.9 %id)
AU145302.
matches multiple genes
whole embryo, mainly head .a 3242 to 3787 544 to 1     also hits gene sehiri 544/549
(99 %)
8 diff
(98.6 %id)
FN046367 breast carcinoma .a 3255 to 3307 53 to 1     Submitted on the opposite strand 53/54
(98 %)
1 diff
(98.2 %id)
BM689650 eye, Retina Foveal and Macular .a 3267 to 3734 1 to 468       468/468
(100 %)
5 diff
(99.0 %id)
AW445159   .a 3282 to 3804 523 to 1       523/523
(100 %)
0 diff
(100 %id)
TI_151697223   .a 3287 to 3787 618 to 118   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 501/501
(100 %)
0 diff
(100 %id)
AW888628 nervous_tumor .a 3289 to 3602 1 to 314       314/314
(100 %)
3 diff
(99.1 %id)
AW888627 nervous_tumor .a 3298 to 3702 1 to 405       405/405
(100 %)
2 diff
(99.6 %id)
AI088482 uterus .a 3307 to 3787 481 to 1       481/481
(100 %)
3 diff
(99.4 %id)
N52314 multiple sclerosis lesions .a 3315 to 3593 279 to 1       279/279
(100 %)
0 diff
(100 %id)
H25289 breast .a 3387 to 3777 415 to 11   fully sequenced,   405/415
(97 %)
19 diff
(95.5 %id)
T66784 whole brain .a 3428 to 3795 373 to 1       373/460
(81 %)
11 diff
(97.7 %id)
AA167189   .a 3448 to 3791 345 to 1       345/345
(100 %)
2 diff
(99.5 %id)
DB359461 whole embryo, mainly body .a 4366 to 4899 533 to 1       533/533
(100 %)
6 diff
(98.9 %id)
DA238313 brain .b 1 to 530 2 to 531   tiling clone, capped   530/530
(100 %)
0 diff
(100 %id)
DB136439 thymus .b 42 to 530 2 to 490   capped   489/489
(100 %)
1 diff
(99.8 %id)
DA063580 cerebellum .b 67 to 636 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA398570 thalamus .b 67 to 633 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA244962 brain .b 110 to 685 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA000993   .b 134 to 648 2 to 516   capped   515/515
(100 %)
2 diff
(99.7 %id)
BI464461 testis .b 175 to 796 1 to 619       619/624
(99 %)
29 diff
(95.4 %id)
BC040481 testis .b 180 to 5092 1 to 4914 V263M H792R tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 4914/4915
(99 %)
6 diff
(99.9 %id)
NM_007222.3   .b 180 to 5098 1 to 4919 exact RefSeq, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 4919/4919
(100 %)
0 diff
(100 %id)
DA231459 brain .b 188 to 722 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
DA116857 cerebellum .b 194 to 739 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BP230384 brain .b 197 to 779 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DB069855 testis .b 199 to 738 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DB447703 testis .b 200 to 649 1 to 449       449/449
(100 %)
15 diff
(96.7 %id)
DB450452 testis .b 200 to 634 1 to 434       434/434
(100 %)
15 diff
(96.6 %id)
DB505742 hypothalamus .b 200 to 704 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
DB237402 trachea .b 200 to 753 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA433749 tongue, tumor tissue .b 202 to 759 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA496090 brain .b 202 to 757 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA505816 brain .b 202 to 779 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA507731 brain .b 202 to 769 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA854536 placenta .b 202 to 761 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BP348954 brain .b 202 to 782 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
DB090315 testis .b 202 to 769 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DB240509 trachea .b 202 to 786 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DB289474 uterus .b 202 to 752 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BP281115 bone marrow .b 203 to 783 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP281150 bone marrow .b 203 to 786 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP315354 mammary gland .b 203 to 785 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP348284 brain .b 203 to 783 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP287596 lung .b 204 to 787 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA489554 brain .b 205 to 738 2 to 546   capped   545/545
(100 %)
13 diff
(97.7 %id)
DA984431 synovial membrane tissue from rheumatioidarthritis .b 205 to 772 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BM147935 leukopheresis .b 207 to 714 1 to 508       508/508
(100 %)
4 diff
(99.3 %id)
CD687945 normal nasopharynx .b 208 to 748 39 to 579       541/579
(93 %)
8 diff
(98.7 %id)
CD697856 normal nasopharynx .b 208 to 648 41 to 481       441/481
(91 %)
8 diff
(98.4 %id)
BP229362 brain .b 210 to 794 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BP231200 muscle .b 210 to 790 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA323437 hippocampus .b 211 to 732 2 to 523   capped   522/524
(99 %)
2 diff
(99.7 %id)
BI837174 pooled pancreas and spleen .b 211 to 910 1 to 700       700/702
(99 %)
17 diff
(97.6 %id)
TI_57167853   .b 211 to 910 27 to 726       700/728
(96 %)
14 diff
(98.1 %id)
DA215871 brain .b 214 to 733 2 to 523   capped   522/522
(100 %)
4 diff
(99.3 %id)
DA497320 brain .b 215 to 785 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DA803932 brain .b 215 to 759 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
AL698730 human skeletal muscle .b 219 to 812 1 to 594       594/594
(100 %)
0 diff
(100 %id)
DA193338 amygdala .b 220 to 805 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA309997 hippocampus .b 220 to 793 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA437535 tongue, tumor tissue .b 220 to 768 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA457311 tongue, tumor tissue .b 220 to 796 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DA619337   .b 220 to 542 2 to 324   capped   323/323
(100 %)
0 diff
(100 %id)
AU280170   .b 220 to 780 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
DA864318 placenta .b 220 to 805 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DB164112 thymus .b 220 to 805 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
BP363351 lung .b 220 to 803 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
DB230969 trachea .b 220 to 804 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
DB278336 uterus .b 220 to 750 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA177813 amygdala .b 221 to 733 2 to 516   capped   515/515
(100 %)
3 diff
(99.5 %id)
DA189384 amygdala .b 221 to 792 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA387397 thalamus .b 221 to 795 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
BP286257 lung .b 221 to 802 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DB137610 thymus .b 221 to 767 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DB213703 trachea .b 221 to 763 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB213970 trachea .b 221 to 763 2 to 546   capped   545/545
(100 %)
3 diff
(99.5 %id)
DA811098 brain .b 223 to 781 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BP285735 lung .b 224 to 805 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BQ581361 insulinoma, Pancreas .b 235 to 683 7 to 456       450/489
(92 %)
3 diff
(99.4 %id)
AF195766   .b 237 to 4812 1 to 4570 exact tiling clone,   4570/4570
(100 %)
10 diff
(99.8 %id)
BI032554 nervous_normal .c 1 to 237 1 to 236   tiling clone,   236/236
(100 %)
17 diff
(92.8 %id)
AW015967   .c 1 to 273 284 to 12 L50V tiling clone,   273/284
(96 %)
0 diff
(100 %id)
AK289532 cerebellum .c 39 to 3395 1 to 3357 L601S K629E tiling clone,   3357/3357
(100 %)
2 diff
(100.0 %id)
DC308095 cerebellum .c 39 to 623 1 to 585       585/585
(100 %)
0 diff
(100 %id)
DC296596 synovial membrane tissue from rheumatioidarthritis .c 59 to 607 1 to 549       549/549
(100 %)
0 diff
(100 %id)
DC350825 brain .c 77 to 638 1 to 565       565/565
(100 %)
5 diff
(99.2 %id)
BM969111 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 88 to 269 198 to 17   tiling clone, AAA   182/182
(100 %)
0 diff
(100 %id)
AW058463 Kidney .c 121 to 580 459 to 1       459/459
(100 %)
2 diff
(99.6 %id)
DC309151 cerebellum .c 207 to 797 1 to 591       591/591
(100 %)
0 diff
(100 %id)
DR156993 human embryonic stem cells differentiated toan early endodermal cell type .d 1 to 802 1 to 802   tiling clone,   802/802
(100 %)
0 diff
(100 %id)
CB990239 Human Placenta, placenta .d 18 to 591 24 to 602       579/851
(68 %)
21 diff
(97.6 %id)
AK027731 ovary, tumor tissue .d 22 to 1307 1 to 1286 exact available from FLJ,   1286/1286
(100 %)
0 diff
(100 %id)
BP233441 coronary artery .d 22 to 574 1 to 553       553/555
(99 %)
4 diff
(99.3 %id)
BI548630 brain, hippocampus .d 22 to 552 1 to 534       534/534
(100 %)
12 diff
(97.8 %id)
NM_032847.1   .d 22 to 1307 1 to 1286 exact RefSeq,   1286/1286
(100 %)
0 diff
(100 %id)
BP329585 rectum .d 22 to 606 1 to 587       587/587
(100 %)
14 diff
(97.7 %id)
DA282505 corpus callosum .d 23 to 571 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA812133 ovary, tumor tissue .d 23 to 801 2 to 787   fully sequenced, capped   786/786
(100 %)
4 diff
(99.5 %id)
DA900132 skeletal muscle .d 23 to 567 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA902887   .d 25 to 587 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BC067796 Brain, hippocampus .d 27 to 1331 1 to 1305 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1305/1306
(99 %)
1 diff
(100.0 %id)
CD110179 placenta, pre-eclamptic placenta .d 27 to 714 28 to 723       696/871
(79 %)
19 diff
(97.9 %id)
TI_44167133   .d 27 to 552 127 to 655       529/655
(80 %)
13 diff
(98.1 %id)
BP330657 rectum .d 27 to 606 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BP339933 Spleen .d 28 to 552 1 to 525       525/584
(89 %)
22 diff
(96.3 %id)
CN366811 embryonic stem cells, DMSO-treated H9 cellline .d 30 to 692 1 to 664       664/664
(100 %)
8 diff
(98.8 %id)
BX480207   .d 32 to 566 1 to 535       535/535
(100 %)
1 diff
(99.9 %id)
CR593173 Neuroblastoma Cot 50-normalized .d 36 to 1313 1 to 1278 exact     1278/1278
(100 %)
0 diff
(100 %id)
AL529762 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 36 to 863 1 to 827   fully sequenced,   827/827
(100 %)
2 diff
(99.8 %id)
DR005135 Prostate .d 36 to 647 1 to 613       613/613
(100 %)
15 diff
(97.6 %id)
CR604160 fetal liver .d 39 to 1273 1 to 1235 exact     1235/1235
(100 %)
0 diff
(100 %id)
BX427353 fetal liver, Liver .d 39 to 410 1 to 372   fully sequenced,   372/372
(100 %)
3 diff
(99.2 %id)
BQ918272 large cell carcinoma, lung .d 40 to 984 1 to 955       955/955
(100 %)
13 diff
(98.7 %id)
AA356792   .d 43 to 334 1 to 292       292/293
(99 %)
1 diff
(99.7 %id)
FN126245 breast carcinoma .d 43 to 103 61 to 1     Submitted on the opposite strand 61/71
(85 %)
0 diff
(100 %id)
BP263429 small intestine .d 48 to 629 1 to 584       584/584
(100 %)
6 diff
(99.0 %id)
CD705122 normal nasopharynx .d 50 to 598 21 to 569       549/569
(96 %)
9 diff
(98.5 %id)
AK222660 cerebellum .d 53 to 1325 1 to 1273 H373R tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1273/1273
(100 %)
2 diff
(99.9 %id)
BP211229 cerebellum .d 53 to 646 1 to 593       593/593
(100 %)
2 diff
(99.7 %id)
DA848046 placenta .d 54 to 512 2 to 461   capped   460/460
(100 %)
1 diff
(99.8 %id)
AW603042 breast .d 55 to 410 8 to 364       357/407
(87 %)
8 diff
(98.1 %id)
CR594463 fetal brain .d 55 to 1282 1 to 1228       1228/1228
(100 %)
0 diff
(100 %id)
AL540182 brain, fetal brain .d 55 to 1002 1 to 952       950/952
(99 %)
4 diff
(99.6 %id)
DA729447   .d 56 to 730 2 to 673   capped   672/675
(99 %)
6 diff
(99.2 %id)
DR156431 human embryonic stem cells differentiated toan early endodermal cell type .d 60 to 801 1 to 742       742/742
(100 %)
0 diff
(100 %id)
AA294847 Pancreas .d 61 to 273 10 to 221       212/221
(95 %)
6 diff
(97.3 %id)
CX164518 human embryonic stem cells differentiated toan early endodermal cell type .d 61 to 878 1 to 818       818/818
(100 %)
0 diff
(100 %id)
CX751163 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 61 to 787 1 to 727     Submitted on the opposite strand 727/736
(98 %)
3 diff
(99.6 %id)
BG696610 skin .d 68 to 853 1 to 788       788/789
(99 %)
11 diff
(98.7 %id)
BE563497 adenocarcinoma, Pancreas .d 84 to 869 1 to 775       775/972
(79 %)
26 diff
(97.4 %id)
AA451984   .d 89 to 440 1 to 350       350/350
(100 %)
2 diff
(99.5 %id)
DW421122 Liver .d 97 to 377 18 to 298       281/298
(94 %)
7 diff
(97.7 %id)
BG960867 colon .d 117 to 360 37 to 285       249/289
(86 %)
18 diff
(93.8 %id)
AA312205   .d 134 to 468 1 to 335       335/335
(100 %)
0 diff
(100 %id)
AW965801   .d 135 to 832 1 to 695       695/696
(99 %)
18 diff
(97.5 %id)
W81628 heart .d 249 to 553 1 to 306       306/306
(100 %)
2 diff
(99.4 %id)
BG679527 skin, squamous cell carcinoma .d 265 to 1061 1 to 801       801/801
(100 %)
14 diff
(98.3 %id)
AA281527 germinal center B cell .d 282 to 728 1 to 447       447/447
(100 %)
0 diff
(100 %id)
H96359 placenta .d 311 to 756 1 to 461       461/464
(99 %)
20 diff
(95.7 %id)
N57426 placenta .d 312 to 786 1 to 475       475/475
(100 %)
0 diff
(100 %id)
BX427352 fetal liver, Liver .d 379 to 1273 895 to 1   fully sequenced,   895/895
(100 %)
18 diff
(98.0 %id)
CR738764 liver and spleen .d 395 to 1049 1 to 655       655/655
(100 %)
0 diff
(100 %id)
BM473239 leiomyosarcoma, uterus .d 419 to 1056 94 to 733   AAA   640/1466
(43 %)
23 diff
(98.5 %id)
BM451556 eye, retinoblastoma .d 465 to 1309 1 to 845       845/863
(97 %)
9 diff
(99.0 %id)
CN366812 embryonic stem cells, DMSO-treated H9 cellline .d 468 to 1174 1 to 709       709/709
(100 %)
3 diff
(99.6 %id)
BX352279.
matches multiple genes
  .d 479 to 1304 828 to 1     also hits gene CLPB 828/906
(91 %)
17 diff
(98.2 %id)
W30844 senescent fibroblast .d 518 to 984 1 to 490   fully sequenced, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 490/490
(100 %)
28 diff
(94.3 %id)
CD370679 Alveolar Macrophage, lung .d 555 to 1307 767 to 17   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 751/751
(100 %)
10 diff
(98.7 %id)
BQ574576 Chondrosarcoma Grade II, Left Pelvis .d 567 to 1218 671 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 653/653
(100 %)
1 diff
(99.9 %id)
CD368872 Alveolar Macrophage, lung .d 589 to 1307 736 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 718/718
(100 %)
1 diff
(99.9 %id)
CD368543 Alveolar Macrophage, lung .d 594 to 1307 730 to 17   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 714/714
(100 %)
2 diff
(99.8 %id)
CB529928 Aveolar Macrophage, lung .d 598 to 1305 726 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 708/708
(100 %)
0 diff
(100 %id)
BM712611 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 654 to 949 1 to 296   fully sequenced, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 296/296
(100 %)
0 diff
(100 %id)
CA423565 cell lines, Chondrosarcoma .d 666 to 1330 681 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 663/663
(100 %)
2 diff
(99.7 %id)
BM990290 lung, Metastatic Chondrosarcoma .d 668 to 1307 656 to 17   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 640/640
(100 %)
2 diff
(99.7 %id)
CA429812 Cell Line, Chondrosarcoma .d 668 to 1311 658 to 15       644/658
(97 %)
0 diff
(100 %id)
TI_151719968   .d 677 to 1330 731 to 73   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 659/1232
(53 %)
11 diff
(99.2 %id)
AA626793 whole brain .d 729 to 1307 579 to 1       579/579
(100 %)
0 diff
(100 %id)
DB371444 ovary, tumor tissue .d 771 to 1307 533 to 1   fully sequenced,   533/533
(100 %)
5 diff
(99.1 %id)
BE153791 head_neck .d 786 to 1032 253 to 5     Submitted on the opposite strand 247/299
(82 %)
11 diff
(96.4 %id)
AI149147 placenta .d 798 to 1306 509 to 1       509/509
(100 %)
0 diff
(100 %id)
BI818661 pooled brain, lung, testis .d 810 to 1307 1 to 496   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 496/496
(100 %)
2 diff
(99.6 %id)
TI_57196571   .d 810 to 1307 35 to 530   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 496/530
(93 %)
8 diff
(98.5 %id)
AW025864 thymus, pooled .d 824 to 1307 487 to 1       487/487
(100 %)
4 diff
(99.2 %id)
N32331 placenta .d 836 to 1307 476 to 1       476/476
(100 %)
5 diff
(99.0 %id)
AL563543 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .d 837 to 1313 477 to 1   fully sequenced,   477/477
(100 %)
7 diff
(98.6 %id)
TI_57162265   .d 837 to 1326 36 to 524       489/524
(93 %)
10 diff
(98.1 %id)
BI832736 pooled pancreas and spleen .d 838 to 1326 1 to 488       488/488
(100 %)
3 diff
(99.4 %id)
H13510 placenta .d 847 to 1220 1 to 375       375/375
(100 %)
6 diff
(98.4 %id)
AA811125 germinal center B cell .d 849 to 1307 471 to 13   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 459/459
(100 %)
0 diff
(100 %id)
AA973041 pooled .d 849 to 1308 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AW341196 carcinoid, lung .d 852 to 1326 479 to 5       475/479
(99 %)
0 diff
(100 %id)
AW269550 pooled .d 858 to 1307 450 to 1       450/450
(100 %)
0 diff
(100 %id)
AI078419 liver and spleen .d 859 to 1309 451 to 1       451/451
(100 %)
0 diff
(100 %id)
BG218640   .d 862 to 1330 1 to 468   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 467/468
(99 %)
7 diff
(98.6 %id)
AI858149 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 862 to 1305 444 to 1       444/444
(100 %)
0 diff
(100 %id)
H96360 placenta .d 865 to 1267 403 to 1       403/403
(100 %)
2 diff
(99.6 %id)
AA936889 squamous cell carcinoma from base of tongue, tongue .d 870 to 1275 406 to 1       406/406
(100 %)
0 diff
(100 %id)
AW275545 pooled .d 873 to 1307 436 to 1       436/437
(99 %)
7 diff
(98.4 %id)
AA831209 germinal center B cell .d 875 to 1307 445 to 13   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 433/433
(100 %)
0 diff
(100 %id)
AI799151 pooled .d 876 to 1221 346 to 1       346/346
(100 %)
4 diff
(98.9 %id)
AI087365 senescent fibroblast .d 894 to 1311 419 to 2       418/419
(99 %)
0 diff
(100 %id)
N48251 multiple sclerosis lesions .d 897 to 1307 412 to 1       412/412
(100 %)
3 diff
(99.3 %id)
AA971571 pooled .d 897 to 1308 412 to 1       412/412
(100 %)
0 diff
(100 %id)
AI767131 2 pooled tumors (clear cell type), Kidney .d 898 to 1310 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
H94323 liver and spleen .d 901 to 1307 408 to 1       408/408
(100 %)
2 diff
(99.6 %id)
AI818072 lymph node, lymphoma, follicular mixed small and largecell .d 908 to 1307 400 to 1       400/400
(100 %)
0 diff
(100 %id)
AI000710 Kidney .d 910 to 1325 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AA730481 Ewing's sarcoma .d 919 to 1051 1 to 133       133/133
(100 %)
1 diff
(99.3 %id)
BU738334 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 919 to 1330 430 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 412/412
(100 %)
0 diff
(100 %id)
AA281528 germinal center B cell .d 928 to 1307 380 to 1       380/380
(100 %)
0 diff
(100 %id)
AW170509 cervix, tumor .d 928 to 1307 380 to 1       380/380
(100 %)
0 diff
(100 %id)
W81370 heart .d 929 to 1307 382 to 1       382/382
(100 %)
4 diff
(99.0 %id)
AI301505 2 pooled tumors (clear cell type), Kidney .d 935 to 1307 401 to 29   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 373/373
(100 %)
6 diff
(98.4 %id)
AI928296 2 pooled tumors (clear cell type), Kidney .d 943 to 1311 470 to 3       325/470
(69 %)
4 diff
(99.2 %id)
AA749459 germinal center B cell .d 947 to 1328 389 to 7       381/389
(97 %)
1 diff
(99.8 %id)
AA954535 pooled .d 947 to 1307 361 to 1       361/361
(100 %)
1 diff
(99.8 %id)
AA515033 colon .d 949 to 1307 359 to 1       359/359
(100 %)
0 diff
(100 %id)
AA700795 liver and spleen .d 959 to 1307 349 to 1       349/349
(100 %)
0 diff
(100 %id)
N94553 senescent fibroblast .d 960 to 1307 360 to 12   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 349/349
(100 %)
2 diff
(99.5 %id)
AA584953 germ cell tumor .d 960 to 1311 352 to 1       352/352
(100 %)
0 diff
(100 %id)
AI160322 heart .d 960 to 1328 373 to 5       369/373
(98 %)
0 diff
(100 %id)
AI362012 brain, glioblastoma (pooled) .d 981 to 1330 373 to 24   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 350/350
(100 %)
5 diff
(98.6 %id)
BG209690   .d 999 to 1307 1 to 308   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 308/308
(100 %)
13 diff
(95.8 %id)
AI014406 Kidney .d 999 to 1310 312 to 1       312/312
(100 %)
0 diff
(100 %id)
AI638443 pooled germ cell tumors .d 999 to 1221 250 to 28       223/251
(88 %)
0 diff
(100 %id)
FN072819 breast carcinoma .d 1027 to 1100 1 to 74       74/78
(94 %)
2 diff
(97.5 %id)
EC500428 Prostate .d 1032 to 1133 1 to 104       104/104
(100 %)
3 diff
(97.2 %id)
BM715992 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 1069 to 1307 1 to 239   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 239/239
(100 %)
0 diff
(100 %id)
EC476499 Prostate .d 1073 to 1158 86 to 1       86/91
(94 %)
3 diff
(96.8 %id)
FN176217 breast carcinoma .d 1074 to 1175 1 to 102       102/102
(100 %)
0 diff
(100 %id)
EC498266 Prostate .d 1083 to 1173 9 to 97       89/97
(91 %)
6 diff
(93.9 %id)
AI383042 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 1121 to 1307 189 to 1       189/189
(100 %)
2 diff
(99.0 %id)
AA174181   .d 1190 to 1298 108 to 1       108/108
(100 %)
1 diff
(99.1 %id)
EC529299 Prostate .d 1191 to 1303 112 to 2       111/112
(99 %)
0 diff
(100 %id)
EC542305 Prostate .d 1191 to 1303 113 to 2       112/113
(99 %)
0 diff
(100 %id)
EC441480 Prostate .d 1198 to 1306 109 to 3       107/109
(98 %)
0 diff
(100 %id)
EC455680 Prostate .d 1199 to 1305 112 to 4       109/112
(97 %)
0 diff
(100 %id)
FN092474 breast carcinoma .d 1221 to 1323 1 to 103       103/103
(100 %)
0 diff
(100 %id)
AA451944   .e 1 to 397 8 to 403   tiling clone, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 396/403
(98 %)
6 diff
(98.6 %id)
AA478449   .e 896 to 1095 216 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 200/200
(100 %)
0 diff
(100 %id)
BP340117 Spleen .f 1 to 535 4 to 537   tiling clone,   537/581
(92 %)
22 diff
(96.3 %id)
DA893729 skeletal muscle .f 17 to 543 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
BF035882 adenocarcinoma, ovary .f 61 to 505 1 to 451       451/453
(99 %)
10 diff
(97.8 %id)
BC012379 Ovary, adenocarcinoma .f 66 to 1319 1 to 1254 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 1254/1254
(100 %)
0 diff
(100 %id)
CV023581 mixed .f 160 to 802 1 to 642       642/642
(100 %)
3 diff
(99.6 %id)
CN366809 embryonic stem cells, cell lines H1, H7, andH9 .f 189 to 575 1 to 388       388/388
(100 %)
2 diff
(99.5 %id)
BQ425757 melanotic melanoma, skin .f 222 to 1001 5 to 790   AAA   786/831
(94 %)
13 diff
(98.5 %id)
BI087971 cervix .f 223 to 967 1 to 746       746/748
(99 %)
13 diff
(98.3 %id)
BQ891752 carcinoma, cell line, Prostate .f 245 to 748 1 to 512       512/955
(53 %)
21 diff
(97.9 %id)
BF572591 melanotic melanoma, high MDR, skin .f 280 to 987 1 to 708       708/842
(84 %)
21 diff
(97.6 %id)
BM832412 stomach .f 293 to 656 1 to 365       365/365
(100 %)
1 diff
(99.8 %id)
BM833462 stomach .f 293 to 684 1 to 392       392/392
(100 %)
0 diff
(100 %id)
BM834806 stomach .f 294 to 662 1 to 370       370/370
(100 %)
2 diff
(99.5 %id)
BM714805 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 296 to 975 1 to 679       679/679
(100 %)
1 diff
(99.9 %id)
FN049338 breast carcinoma .f 314 to 410 1 to 97       97/97
(100 %)
0 diff
(100 %id)
FN078360 breast carcinoma .f 314 to 410 1 to 97       97/97
(100 %)
2 diff
(98.0 %id)
BE834042 ovary .f 316 to 875 99 to 660       562/661
(85 %)
24 diff
(96.4 %id)
BU785360 Pancreas, Purified pancreatic islet .f 346 to 816 1 to 470       470/470
(100 %)
5 diff
(99.0 %id)
BM852465 stomach .f 354 to 701 1 to 348       348/348
(100 %)
0 diff
(100 %id)
BM888527 eye .f 389 to 921 533 to 1     Submitted on the opposite strand 533/533
(100 %)
0 diff
(100 %id)
H79658 liver and spleen .f 406 to 833 1 to 440       440/460
(95 %)
17 diff
(96.4 %id)
AA095644   .f 415 to 527 12 to 122       111/126
(88 %)
8 diff
(93.7 %id)
AW371970 breast .f 434 to 1011 639 to 60       580/648
(89 %)
9 diff
(98.7 %id)
BM693277 eye, Retina Foveal and Macular .f 456 to 767 1 to 312       312/312
(100 %)
3 diff
(99.1 %id)
AI767192 2 pooled tumors (clear cell type), Kidney .f 538 to 845 315 to 3       313/315
(99 %)
0 diff
(100 %id)
W30890 senescent fibroblast .f 550 to 730 1 to 181       181/181
(100 %)
0 diff
(100 %id)
AW752006 colon .f 558 to 952 1 to 401       395/401
(98 %)
25 diff
(93.8 %id)
AW752005 colon .f 608 to 955 351 to 1       351/351
(100 %)
15 diff
(95.8 %id)
FN134721 breast carcinoma .f 610 to 708 101 to 1     Submitted on the opposite strand 101/101
(100 %)
2 diff
(98.1 %id)
AL583209 B cells from Burkitt lymphoma .f 725 to 1290 570 to 1       570/570
(100 %)
23 diff
(96.0 %id)
FN075033 breast carcinoma .f 806 to 869 1 to 64       64/65
(98 %)
1 diff
(98.5 %id)
FN148912 breast carcinoma .f 896 to 1004 107 to 1     Submitted on the opposite strand 107/107
(100 %)
2 diff
(98.2 %id)
AI247784 liver and spleen .f 908 to 1007 100 to 1       100/100
(100 %)
0 diff
(100 %id)
FN085986 breast carcinoma .f 913 to 974 61 to 1     Submitted on the opposite strand 61/62
(98 %)
1 diff
(98.4 %id)
DR762931 embryonic stem .g 1 to 836 1 to 835   tiling clone,   835/835
(100 %)
1 diff
(99.9 %id)
CN366810 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 77 to 540 1 to 464       464/464
(100 %)
5 diff
(99.0 %id)
AI962386 pooled germ cell tumors .g 417 to 1248 523 to 1   tiling clone, Suspected internal deletion 523/523
(100 %)
3 diff
(99.5 %id)
AW295290   .g 463 to 1247 491 to 18   tiling clone, AAA Suspected internal deletion, possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 474/474
(100 %)
5 diff
(99.0 %id)
TI_149313752   .h 1 to 809 898 to 88 T4X L9V T10X L17X I19X ... tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 811/951
(85 %)
5 diff
(99.5 %id)
CB305601 lung, Primary Lung Cystic Fibrosis EpithelialCells .h 135 to 809 695 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 677/677
(100 %)
4 diff
(99.5 %id)
CB144615 Liver .h 164 to 648 1 to 485       485/485
(100 %)
0 diff
(100 %id)
AW339209 adenocarcinoma, Pancreas .h 532 to 817 288 to 3   tiling clone,   286/288
(99 %)
0 diff
(100 %id)
CB156214 Liver .i 1 to 569 1 to 569 exact tiling clone,   569/569
(100 %)
0 diff
(100 %id)
CB160468 Liver .i 1 to 547 1 to 547 exact     547/547
(100 %)
0 diff
(100 %id)
CB160472 Liver .i 1 to 480 1 to 480 exact     480/480
(100 %)
0 diff
(100 %id)
BG195707   .i 482 to 807 63 to 388   tiling clone,   326/833
(39 %)
6 diff
(99.3 %id)
CA393874 eye, RPE/choroid .j-u 1 to 551 1 to 543   tiling clone,   543/543
(100 %)
11 diff
(98.0 %id)
AW795793 uterus .j-u 236 to 805 568 to 1       568/568
(100 %)
0 diff
(100 %id)
CA868180 Pancreas, Purified pancreatic islet .j-u 239 to 787 1 to 550       550/550
(100 %)
4 diff
(99.3 %id)
CA842387 Pancreas, Purified pancreatic islet .j-u 306 to 715 1 to 410   fully sequenced,   410/410
(100 %)
0 diff
(100 %id)
BQ130087 insulinoma, Pancreas .j-u 309 to 882 1 to 574     Submitted on the opposite strand 574/574
(100 %)
0 diff
(100 %id)
CK905813 insulinoma, Pancreas .j-u 309 to 917 1 to 609   tiling clone, Submitted on the opposite strand 609/609
(100 %)
0 diff
(100 %id)
BX100353 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 314 to 683 1 to 370       370/370
(100 %)
0 diff
(100 %id)
FN145320 breast carcinoma .j-u 323 to 423 102 to 1     Submitted on the opposite strand 102/102
(100 %)
1 diff
(99.1 %id)
BP398444 pancreatic islet .j-u 334 to 832 500 to 1       500/500
(100 %)
1 diff
(99.8 %id)
AA181564   .j-u 352 to 761 1 to 409     Submitted on the opposite strand 409/409
(100 %)
1 diff
(99.8 %id)
AW860918 colon .j-u 420 to 946 528 to 1       528/528
(100 %)
4 diff
(99.3 %id)
FN088352 breast carcinoma .j-u 420 to 499 81 to 1     Submitted on the opposite strand 81/82
(98 %)
1 diff
(98.8 %id)
AW860916 colon .j-u 444 to 946 505 to 1       505/505
(100 %)
3 diff
(99.5 %id)
AU147724 mammary gland .j-u 587 to 1126 543 to 1       543/547
(99 %)
10 diff
(98.2 %id)
AA384123 thyroid gland .j-u 594 to 923 1 to 332       332/332
(100 %)
2 diff
(99.4 %id)
TI_151770469   .j-u 595 to 1143 98 to 645   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 548/1077
(50 %)
25 diff
(97.7 %id)
BQ130337 insulinoma, Pancreas .j-u 637 to 1143 525 to 17   AAA Submitted on the opposite strand 509/525
(96 %)
0 diff
(100 %id)
AW665708 pooled .j-u 652 to 1127 476 to 1       476/476
(100 %)
2 diff
(99.6 %id)
AA813065   .j-u 655 to 1130 476 to 1       476/476
(100 %)
0 diff
(100 %id)
AA743699 germinal center B cell .j-u 666 to 1135 468 to 1       468/468
(100 %)
2 diff
(99.6 %id)
CA842912 Pancreas, Purified pancreatic islet .j-u 685 to 1125 441 to 1   fully sequenced,   441/441
(100 %)
0 diff
(100 %id)
BU732558 eye, optic nerve .j-u 695 to 1143 450 to 2   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 449/450
(99 %)
0 diff
(100 %id)
AW298305   .j-u 716 to 1143 430 to 1       430/430
(100 %)
1 diff
(99.8 %id)
AA182459   .j-u 720 to 1089 373 to 1     Submitted on the opposite strand 373/373
(100 %)
3 diff
(99.2 %id)
AI276079 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .j-u 722 to 1126 405 to 1       405/405
(100 %)
0 diff
(100 %id)
AA983958 pooled .j-u 819 to 1127 309 to 1       309/309
(100 %)
1 diff
(99.7 %id)
AA651829 germinal center B cell .j-u 854 to 1124 284 to 12   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 273/284
(96 %)
0 diff
(100 %id)
AA380925   .j-u 1088 to 1366 1 to 279       279/279
(100 %)
0 diff
(100 %id)
AA487404   .j-u 1089 to 1505 1 to 417   tiling clone,   417/417
(100 %)
2 diff
(99.6 %id)
BM909843 astrocytoma grade IV, cell line, brain .j-u 1147 to 2062 23 to 960 G24X A66C L67F E68G R69E ... tiling clone,   938/1100
(85 %)
35 diff
(96.9 %id)
FN099792 breast carcinoma .j-u 1311 to 1407 98 to 1     Submitted on the opposite strand 98/98
(100 %)
1 diff
(99.0 %id)
FN050447 breast carcinoma .j-u 1436 to 1544 109 to 1     Submitted on the opposite strand 109/110
(99 %)
0 diff
(100 %id)
CA424676 cell lines, Chondrosarcoma .j-u 1550 to 2210 677 to 17 exact tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 661/661
(100 %)
0 diff
(100 %id)
AW393332 stomach .j-u 1588 to 2175 594 to 8 V7W G8V T9P C10A L12*     587/595
(98 %)
0 diff
(100 %id)
AA487287   .j-u 1759 to 2161 403 to 1       403/403
(100 %)
0 diff
(100 %id)
AA995999 2 pooled tumors (clear cell type), Kidney .j-u 1765 to 2209 449 to 5       445/450
(98 %)
0 diff
(100 %id)
AW264654 lung, two pooled squamous cell carcinomas .j-u 1832 to 2209 380 to 3       378/380
(99 %)
0 diff
(100 %id)
AA858070 Kidney .j-u 1880 to 2208 342 to 14   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 329/329
(100 %)
0 diff
(100 %id)
BX108550 uterus .k 1 to 702 56 to 757 exact tiling clone,   702/757
(92 %)
6 diff
(99.3 %id)
AA032012 uterus .k 2 to 210 1 to 206       206/206
(100 %)
3 diff
(98.6 %id)
AA032013 uterus .k 608 to 860 256 to 2   tiling clone,   255/256
(99 %)
0 diff
(100 %id)
DA905279   .l 1 to 490 2 to 491 exact tiling clone, capped   490/490
(100 %)
0 diff
(100 %id)
DA852025 placenta .n 1 to 542 2 to 544   tiling clone, capped   543/543
(100 %)
3 diff
(99.5 %id)
DA532611 brain .n 327 to 894 2 to 569   tiling clone, capped   568/568
(100 %)
2 diff
(99.7 %id)
AK055796 Kidney .n 368 to 2960 1 to 2593 exact tiling clone, available from FLJ,   2593/2593
(100 %)
8 diff
(99.7 %id)
DA624759 Kidney .n 369 to 919 2 to 553   capped   552/553
(99 %)
4 diff
(99.3 %id)
AU184912 skin .n 630 to 831 1 to 202       202/202
(100 %)
0 diff
(100 %id)
DB320574 Kidney .n 2403 to 2960 563 to 1       563/563
(100 %)
7 diff
(98.8 %id)
AW192808 adenocarcinoma, Pancreas .n 2438 to 2946 511 to 2       510/511
(99 %)
0 diff
(100 %id)
BX506134   .n 2613 to 2942 355 to 26   AAA Submitted on the opposite strand 330/330
(100 %)
1 diff
(99.7 %id)
AK094451 cerebellum .o 1 to 1838 1 to 1839 exact tiling clone, available from FLJ,   1839/1839
(100 %)
3 diff
(99.9 %id)
DA072274 cerebellum .o 2 to 573 2 to 573 exact capped   572/572
(100 %)
0 diff
(100 %id)
DA303910 hippocampus .o 3 to 563 2 to 562 exact capped   561/561
(100 %)
0 diff
(100 %id)
DA171087 amygdala .o 5 to 542 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
AW274674 pooled .o 239 to 725 487 to 1       487/487
(100 %)
0 diff
(100 %id)
DB297580 cerebellum .o 1291 to 1838 549 to 1       549/549
(100 %)
2 diff
(99.7 %id)
BG928245 cartilage .p-u 1 to 541 86 to 626 exact tiling clone,   541/563
(96 %)
1 diff
(99.9 %id)
D63227   .p-u 86 to 468 1 to 383       383/383
(100 %)
0 diff
(100 %id)
D78795 placenta .p-u 86 to 287 1 to 202       202/202
(100 %)
5 diff
(97.6 %id)
CN412748 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .p-u 130 to 794 1 to 665       665/665
(100 %)
0 diff
(100 %id)
AI873909 serous papillary carcinoma, high grade, 2pooled tumors, uterus .p-u 323 to 664 343 to 1       343/343
(100 %)
1 diff
(99.8 %id)
N98474 multiple sclerosis lesions .p-u 440 to 906 1 to 476   fully sequenced,   476/476
(100 %)
11 diff
(97.7 %id)
AW955720   .p-u 494 to 1140 1 to 647   tiling clone, AAA   647/647
(100 %)
1 diff
(99.9 %id)
AA365372 pineal body .p-u 503 to 729 1 to 229       229/230
(99 %)
4 diff
(98.3 %id)
BI335101 cervical carcinoma cell line, cervix .p-u 509 to 997 1 to 497       497/665
(74 %)
29 diff
(95.7 %id)
CA848306 Pancreas, Purified pancreatic islet .p-u 565 to 1139 575 to 1       575/575
(100 %)
1 diff
(99.9 %id)
BM458258 lymph, lymphoma, cell line .p-u 581 to 1523 1 to 940   tiling clone,   940/1103
(85 %)
36 diff
(96.8 %id)
BE868191 adenocarcinoma, colon .p-u 602 to 1143 1 to 541       541/848
(63 %)
3 diff
(99.7 %id)
AI686834 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .p-u 643 to 1140 496 to 1       496/496
(100 %)
3 diff
(99.4 %id)
BP396685 pancreatic islet .p-u 704 to 1143 1 to 440     Submitted on the opposite strand 440/443
(99 %)
1 diff
(99.8 %id)
AA878475 carcinoid, lung .p-u 706 to 1143 444 to 7       438/444
(98 %)
0 diff
(100 %id)
AI653502 ovary, tumor, 5 pooled (see description) .p-u 723 to 1140 436 to 19   AAA   418/418
(100 %)
0 diff
(100 %id)
G36687   .p-u 729 to 1140 413 to 1     Submitted on the opposite strand 413/418
(98 %)
3 diff
(99.3 %id)
AI539525 serous papillary carcinoma, high grade, 2pooled tumors, uterus .p-u 811 to 1140 330 to 1       330/330
(100 %)
0 diff
(100 %id)
DA291723 hippocampus .p-u 844 to 1428 2 to 586   tiling clone, capped   585/585
(100 %)
1 diff
(99.9 %id)
N66085 multiple sclerosis lesions .p-u 876 to 1140 266 to 1   fully sequenced,   266/266
(100 %)
1 diff
(99.7 %id)
TI_57238686   .q 1 to 689 33 to 727 exact tiling clone,   695/859
(80 %)
23 diff
(97.4 %id)
BI912925 brain .q 2 to 689 1 to 694 exact tiling clone,   694/826
(84 %)
15 diff
(98.2 %id)
BM903572 ovary (pool of 3) .q 8 to 558 9 to 559 exact     551/1181
(46 %)
18 diff
(98.5 %id)
CD707099 normal nasopharynx .r 1 to 207 15 to 220   tiling clone,   206/220
(93 %)
7 diff
(96.9 %id)
DA092698 cerebellum .r 49 to 614 2 to 565 exact tiling clone, capped   564/564
(100 %)
2 diff
(99.7 %id)
DA806693 brain .s 1 to 553 5 to 558 A40R E41R S42V A43R A44G ... tiling clone, capped   557/557
(100 %)
2 diff
(99.7 %id)
DB207657 trachea .s 1 to 537 5 to 541 W38* capped   540/540
(100 %)
1 diff
(99.9 %id)
DA231839 brain .s 17 to 592 2 to 577 exact tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
BP373023 umbilical cord .t 1 to 580 1 to 580 exact tiling clone,   580/580
(100 %)
0 diff
(100 %id)
BP228801 brain .u 1 to 578 7 to 584 exact tiling clone,   584/584
(100 %)
2 diff
(99.7 %id)
DB289599 uterus .va 1 to 492 5 to 496 exact tiling clone, capped   495/495
(100 %)
0 diff
(100 %id)
DA281329 corpus callosum .vb 1 to 492 2 to 493 A25T tiling clone, capped   492/492
(100 %)
1 diff
(99.8 %id)
BU618297 Cell Line, Chondrosarcoma Gene ZHX1andC8orf76, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AV691296 hepatocellular carcinoma Gene ZHX1andC8orf76, variant not shown         This clone was ignored    
AV687038 hepatocellular carcinoma Gene ZHX1andC8orf76, variant not shown         This clone was ignored    
AV688145 hepatocellular carcinoma Gene ZHX1andC8orf76, variant not shown         This clone was ignored    
AV690196 hepatocellular carcinoma Gene ZHX1andC8orf76, variant not shown         This clone was ignored    
BM697591 eye, fetal eyes Gene ZHX1andC8orf76, variant not shown         This clone was ignored    
BU735775 eye, fetal eyes Gene ZHX1andC8orf76, variant not shown       AAA This clone was ignored    
DB310347 substantia nigra Gene ZHX1andC8orf76, variant not shown         This clone was ignored    
DA350307 substantia nigra Gene ZHX1andC8orf76, variant not shown       capped This clone was ignored    
DB309408 hippocampus Gene ZHX1andC8orf76, variant not shown         This clone was ignored    
DA326519 hippocampus Gene ZHX1andC8orf76, variant not shown       capped This clone was ignored    
BF696145 brain, primitive neuroectoderm Gene ZHX1andC8orf76, variant not shown         Suspected internal deletion, this clone was ignored    
DA937209 Spleen Gene ZHX1andC8orf76, variant not shown       capped This clone was ignored    
DB332916 Spleen Gene ZHX1andC8orf76, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l, .m-u, .n, .o, .p-u, .q, .r, .s, .t, .u, .va, .vb Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI